Literature DB >> 29408809

FoxO transcription factors are required for hepatic HDL cholesterol clearance.

Samuel X Lee1, Markus Heine2, Christian Schlein2, Rajasekhar Ramakrishnan3, Jing Liu3, Gabriella Belnavis1, Ido Haimi1, Alexander W Fischer2, Henry N Ginsberg3, Joerg Heeren2, Franz Rinninger2,4, Rebecca A Haeusler1,5.   

Abstract

Insulin resistance and type 2 diabetes are associated with low levels of high-density lipoprotein cholesterol (HDL-C). The insulin-repressible FoxO transcription factors are potential mediators of the effect of insulin on HDL-C. FoxOs mediate a substantial portion of insulin-regulated transcription, and poor FoxO repression is thought to contribute to the excessive glucose production in diabetes. In this work, we show that mice with liver-specific triple FoxO knockout (L-FoxO1,3,4), which are known to have reduced hepatic glucose production, also have increased HDL-C. This was associated with decreased expression of the HDL-C clearance factors scavenger receptor class B type I (SR-BI) and hepatic lipase and defective selective uptake of HDL cholesteryl ester by the liver. The phenotype could be rescued by re-expression of SR-BI. These findings demonstrate that hepatic FoxOs are required for cholesterol homeostasis and HDL-mediated reverse cholesterol transport to the liver.

Entities:  

Keywords:  Cholesterol; Insulin signaling; Lipoproteins; Metabolism

Mesh:

Substances:

Year:  2018        PMID: 29408809      PMCID: PMC5873864          DOI: 10.1172/JCI94230

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  87 in total

1.  Hepatic lipase deficiency delays atherosclerosis, myocardial infarction, and cardiac dysfunction and extends lifespan in SR-BI/apolipoprotein E double knockout mice.

Authors:  Sharon L Karackattu; Bernardo Trigatti; Monty Krieger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-01-05       Impact factor: 8.311

2.  Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels.

Authors:  K F Kozarsky; M H Donahee; A Rigotti; S N Iqbal; E R Edelman; M Krieger
Journal:  Nature       Date:  1997-05-22       Impact factor: 49.962

3.  Hepatic lipase deficiency decreases the selective uptake of HDL-cholesteryl esters in vivo.

Authors:  G Lambert; M J Amar; P Martin; J Fruchart-Najib; B Föger; R D Shamburek; H B Brewer; S Santamarina-Fojo
Journal:  J Lipid Res       Date:  2000-05       Impact factor: 5.922

Review 4.  An overview of reverse cholesterol transport.

Authors:  A R Tall
Journal:  Eur Heart J       Date:  1998-02       Impact factor: 29.983

5.  Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake.

Authors:  H L Dichek; W Brecht; J Fan; Z S Ji; S P McCormick; H Akeefe; L Conzo; D A Sanan; K H Weisgraber; S G Young; J M Taylor; R W Mahley
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

6.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.

Authors:  Y Nakashima; A S Plump; E W Raines; J L Breslow; R Ross
Journal:  Arterioscler Thromb       Date:  1994-01

7.  Deficiency of hepatic lipase activity in post-heparin plasma in familial hyper-alpha-triglyceridemia.

Authors:  L A Carlson; L Holmquist; P Nilsson-Ehle
Journal:  Acta Med Scand       Date:  1986

8.  Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.

Authors:  Sekar Kathiresan; Olle Melander; Candace Guiducci; Aarti Surti; Noël P Burtt; Mark J Rieder; Gregory M Cooper; Charlotta Roos; Benjamin F Voight; Aki S Havulinna; Björn Wahlstrand; Thomas Hedner; Dolores Corella; E Shyong Tai; Jose M Ordovas; Göran Berglund; Erkki Vartiainen; Pekka Jousilahti; Bo Hedblad; Marja-Riitta Taskinen; Christopher Newton-Cheh; Veikko Salomaa; Leena Peltonen; Leif Groop; David M Altshuler; Marju Orho-Melander
Journal:  Nat Genet       Date:  2008-01-13       Impact factor: 38.330

9.  A genetically humanized mouse model for hepatitis C virus infection.

Authors:  Marcus Dorner; Joshua A Horwitz; Justin B Robbins; Walter T Barry; Qian Feng; Kathy Mu; Christopher T Jones; John W Schoggins; Maria Teresa Catanese; Dennis R Burton; Mansun Law; Charles M Rice; Alexander Ploss
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

10.  Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1.

Authors:  Mingjian Lu; Min Wan; Karla F Leavens; Qingwei Chu; Bobby R Monks; Sully Fernandez; Rexford S Ahima; Kohjiro Ueki; C Ronald Kahn; Morris J Birnbaum
Journal:  Nat Med       Date:  2012-02-19       Impact factor: 53.440

View more
  6 in total

1.  Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes.

Authors:  Jenny E Kanter; Baohai Shao; Farah Kramer; Shelley Barnhart; Masami Shimizu-Albergine; Tomas Vaisar; Mark J Graham; Rosanne M Crooke; Clarence R Manuel; Rebecca A Haeusler; Daniel Mar; Karol Bomsztyk; John E Hokanson; Gregory L Kinney; Janet K Snell-Bergeon; Jay W Heinecke; Karin E Bornfeldt
Journal:  J Clin Invest       Date:  2019-07-11       Impact factor: 14.808

2.  The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance.

Authors:  Melinde Wijers; Paolo Zanoni; Nalan Liv; Dyonne Y Vos; Michelle Y Jäckstein; Marieke Smit; Sanne Wilbrink; Justina C Wolters; Ydwine T van der Veen; Nicolette Huijkman; Daphne Dekker; Niels Kloosterhuis; Theo H van Dijk; Daniel D Billadeau; Folkert Kuipers; Judith Klumperman; Arnold von Eckardstein; Jan Albert Kuivenhoven; Bart van de Sluis
Journal:  JCI Insight       Date:  2019-06-06

3.  An integrative transcriptional logic model of hepatic insulin resistance.

Authors:  Takumi Kitamoto; Taiyi Kuo; Atsushi Okabe; Atsushi Kaneda; Domenico Accili
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-09       Impact factor: 12.779

Review 4.  The Role of Forkhead Box O in Pathogenesis and Therapy of Diabetes Mellitus.

Authors:  Malgorzata Marchelek-Mysliwiec; Magdalena Nalewajska; Agnieszka Turoń-Skrzypińska; Katarzyna Kotrych; Violetta Dziedziejko; Tadeusz Sulikowski; Andrzej Pawlik
Journal:  Int J Mol Sci       Date:  2022-10-01       Impact factor: 6.208

Review 5.  Recent advances in understanding and managing cholesterol gallstones.

Authors:  Agostino Di Ciaula; Piero Portincasa
Journal:  F1000Res       Date:  2018-09-24

6.  Hepatic FoxOs link insulin signaling with plasma lipoprotein metabolism through an apolipoprotein M/sphingosine-1-phosphate pathway.

Authors:  María Concepción Izquierdo; Niroshan Shanmugarajah; Samuel X Lee; Michael J Kraakman; Marit Westerterp; Takumi Kitamoto; Michael Harris; Joshua R Cook; Galina A Gusarova; Kendra Zhong; Elijah Marbuary; InSug O-Sullivan; Nikolaus Rasmus; Stefania Camastra; Terry G Unterman; Ele Ferrannini; Barry E Hurwitz; Rebecca A Haeusler
Journal:  J Clin Invest       Date:  2022-04-01       Impact factor: 19.456

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.